Vyome Holdings, Inc. (HIND) vs IN8bio, Inc. (INAB)
A side-by-side comparison of Vyome Holdings, Inc. and IN8bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HIND
Vyome Holdings, Inc.
$1.99HealthcareDelayed quote: Oct 6, 2026, 11:32 AM EDT
INAB
IN8bio, Inc.
$1.43HealthcareDelayed quote: Oct 6, 2026, 11:52 AM EDT
Total return — HIND vs INAB
growth of $100 · dividends reinvested · last 5yHIND -100.0% (-93.5%/yr)INAB -99.5% (-65.7%/yr)INAB compounded faster over this window
Log scale — wide-divergence pair
HIND INAB
HIND vs INAB: by the numbers
- •HIND is the larger company ($14M vs $14M market cap).
- •Both run net losses; INAB's is the smaller (0.00% vs -8716.77% net margin).
Metrics side by side
Valuation
| Metric | HIND | INAB |
|---|---|---|
| P/S ratio | 107.67 | N/A |
| P/B ratio | 2.31 | 0.75 |
| FCF yield | 3.76% | N/A |
Profitability
| Metric | HIND | INAB |
|---|---|---|
| Gross margin | 64.68% | 0.00% |
| Operating margin | -859.22% | 0.00% |
| Net margin | -8716.77% | 0.00% |
| ROE | -186.95% | -101.66% |
| ROIC | -57.53% | -91.74% |
Growth (annualized)
| Metric | HIND | INAB |
|---|---|---|
| Revenue CAGR (5Y) | -60.54% | N/A |
| Total return CAGR (5Y) | -92.93% | -62.88% |
Frequently asked
- How have HIND and INAB total returns compared?
- Over the past 5 years, HIND delivered -92.93% and INAB delivered -62.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.